Press Releases + New Year: - Any -2024202320222021202020192018201720162015201420132012201120102009 Items per page 102550 Date Title and Summary View Toggle SummaryJul 11, 2012 Galectin Therapeutics Announces Addition to Russell Microcap Index View HTML Galectin Therapeutics Announces Addition to Russell Microcap Index 14.3 KB Toggle SummaryJun 07, 2012 Galectin Therapeutics to Host Symposium on Galectin Science and Therapeutic Applications September 17-19, 2012 View HTML Galectin Therapeutics to Host Symposium on Galectin Science and Therapeutic Applications September 17-19, 2012 18 KB Toggle SummaryMay 22, 2012 Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders View HTML Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders 14.4 KB Toggle SummaryMay 15, 2012 Galectin Therapeutics Announces Initiation of Phase 1/2 Trial of Novel Combination Therapy for Advanced Metastatic Melanoma View HTML Galectin Therapeutics Announces Initiation of Phase 1/2 Trial of Novel Combination Therapy for Advanced Metastatic Melanoma 17.8 KB Toggle SummaryMay 11, 2012 Galectin Therapeutics Reports First Quarter 2012 Financial Results View HTML Galectin Therapeutics Reports First Quarter 2012 Financial Results 19.1 KB Toggle SummaryMay 01, 2012 Galectin Therapeutics Announces Long-term Engagement of Dr. Scott Friedman to Advise on Liver Fibrosis Programs -Renowned Physician and Researcher in Liver Diseases- View HTML Galectin Therapeutics Announces Long-term Engagement of Dr. Scott Friedman to Advise on Liver Fibrosis Programs 14.6 KB Toggle SummaryApr 16, 2012 Galectin Therapeutics to Present Promising New Therapeutic Approach for Fatty Liver Disease at Digestive Disease Week 2012 View HTML Galectin Therapeutics to Present Promising New Therapeutic Approach for Fatty Liver Disease at Digestive Disease Week 2012 13.5 KB Toggle SummaryMar 30, 2012 Galectin Therapeutics Reports Full Year and Fourth Quarter 2011 Financial Results View HTML Galectin Therapeutics Reports Full Year and Fourth Quarter 2011 Financial Results 18 KB Toggle SummaryMar 28, 2012 Galectin Therapeutics Inc. Announces Closing of Public Offering of 1,333,361 Units View HTML Galectin Therapeutics Inc. Announces Closing of Public Offering of 1,333,361 Units 17.2 KB Toggle SummaryMar 26, 2012 Galectin Therapeutics Inc. Announces Exercise of Over-Allotment Option View HTML Galectin Therapeutics Inc. Announces Exercise of Over-Allotment Option 17.2 KB Pagination First page First Previous page Previous … Page 29 Current page 30 Page 31 Page 32 … Next page Next Last page Last
Galectin Therapeutics to Host Symposium on Galectin Science and Therapeutic Applications September 17-19, 2012 18 KB
Galectin Therapeutics to Hold Conference Call to Provide Update Following Company's Annual Meeting of Shareholders 14.4 KB
Galectin Therapeutics Announces Initiation of Phase 1/2 Trial of Novel Combination Therapy for Advanced Metastatic Melanoma 17.8 KB
Galectin Therapeutics Announces Long-term Engagement of Dr. Scott Friedman to Advise on Liver Fibrosis Programs 14.6 KB
Galectin Therapeutics to Present Promising New Therapeutic Approach for Fatty Liver Disease at Digestive Disease Week 2012 13.5 KB
